Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency

Title
Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency
Authors
Keywords
Lung transplantation, RSV, CLAD, ribavirin
Journal
JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 34, Issue 7, Pages 958-962
Publisher
Elsevier BV
Online
2015-01-17
DOI
10.1016/j.healun.2015.01.009

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started